Zynex Revenue Q/Q
What is the Revenue Q/Q of Zynex?
The Revenue Q/Q of Zynex, Inc. is 19.36%
What is the definition of Revenue Q/Q?
Quarterly revenue growth, year over year, is the increase of a company’s revenue compared to the performance in the corresponding quarter of a previous year expressed as a percentage.
quarterly growth yoy (year over year)
Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.
Revenue Q/Q of companies in the Health Care sector on HKSE compared to Zynex
What does Zynex do?
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
Companies with revenue q/q similar to Zynex
- Japan Tobacco has Revenue Q/Q of 19.34%
- Yatra Online Inc has Revenue Q/Q of 19.34%
- Elemental Royalties Ltd has Revenue Q/Q of 19.35%
- Apontis Pharm. Ag Inh On has Revenue Q/Q of 19.35%
- Royal Nickel has Revenue Q/Q of 19.35%
- Royal Nickel has Revenue Q/Q of 19.35%
- Zynex has Revenue Q/Q of 19.36%
- Tilray has Revenue Q/Q of 19.37%
- ViewRay has Revenue Q/Q of 19.38%
- Polaris has Revenue Q/Q of 19.38%
- Structural Monitoring Systems Plc has Revenue Q/Q of 19.38%
- Public Service Enterprise has Revenue Q/Q of 19.39%
- Pine Cliff has Revenue Q/Q of 19.39%